AI
ANAC

Analytic Investors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Analytic Investors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,350
Closed -$1.1M – 728
2015
Q3 		$1.1M Buy
+9,350
New +$1.22M 0.01% 352
2015
Q1 		– Sell
-15,221
Closed -$491K – 670
2014
Q4 		$491K Buy
+15,221
New +$457K 0.01% 423

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Analytic Investors's ANAC Position: Q4 2015 in Review

Analytic Investors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 9,350 shares — an estimated $1.1M sold.

Analytic Investors first reported a position in ANAC in Q4 2014 and held it in 2 quarters. The position peaked at $1.1M in Q3 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • Analytic Investors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • Analytic Investors sold 9,350 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $1.1M.
  • Analytic Investors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 2 quarters.
  • Analytic Investors's ANACOR PHARMACEUTICALS INC COM position peaked at $1.1M in Q3 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Analytic Investors's 13F filing for Q4 2015, filed 12 Feb 2016.